4,444,444 Shares(1) Trovagene, Inc. Common Stock, $0.0001 par value PURCHASE AGREEMENTPurchase Agreement • February 6th, 2015 • Trovagene, Inc. • Biological products, (no disgnostic substances) • New York
Trovagene, Inc., a Delaware corporation (the “Company”) proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) 4,444,444 shares (the “Firm Shares”) of Common Stock, $0.0001 par value per share (the “Common Stock”), of the Company, all of which are authorized but unissued shares of Common Stock. The Company has also granted to the several Underwriters an option to purchase up to 666,666 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
